Association of race and margin status among patients undergoing robotic partial nephrectomy for T1 renal cell carcinoma: Results from a population-based cohort
- PMID: 28781110
- DOI: 10.1016/j.urolonc.2017.07.011
Association of race and margin status among patients undergoing robotic partial nephrectomy for T1 renal cell carcinoma: Results from a population-based cohort
Abstract
Objective: To assess the relationship of race and margin status among patients undergoing robotic partial nephrectomy (RPN) for T1 renal tumors from a contemporary population-based cohort.
Methods: Using the National Cancer Database, we identified patients with localized renal cell carcinoma (RCC) (clinical T1N0M0) who underwent RPN from 2010 to 2013. The primary outcome was positive surgical margins (PSM). Multivariable logistic regression analyses were used to assess the association between race and PSM adjusting for patient clinicopathologic and hospital factors.
Results: Among 12,515 patients undergoing RPN in our cohort, 8.3% had PSM (n = 1,045). When compared to white patients undergoing RPN for T1 RCC with PSM (7.9%), we observed a higher proportion of PSM among African American (AA) (10.8%; P = 0.005) and Hispanic/Latino patients (8.8%; P = 0.005), respectively. On multivariable analysis, AA patients had higher odds of PSM compared to white patients (odds ratio = 1.40; P = 0.008). Other factors associated with higher odds of PSM were treatment at nonacademic centers relative to academic centers (10.4% vs. 6.9%; odds ratio = 1.57; P<0.001).
Conclusions: In this contemporary population-based cohort, AA patients undergoing RPN for localized RCC tumors are at higher risk for PSM. These results suggest potential differences in quality of care and patient selection of RPN by race.
Keywords: Healthcare Disparities; Kidney cancer; Positive margins; Race; Renal cell carcinoma; Robotic partial nephrectomy; Surgery.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.Eur Urol. 2016 Jun;69(6):1149-54. doi: 10.1016/j.eururo.2015.12.004. Epub 2015 Dec 22. Eur Urol. 2016. PMID: 26719014
-
Evaluation of oncological outcomes of robotic partial nephrectomy according to the type of hilar control approach (On-clamp vs Off-clamp), a multicentric study of the French network of research on kidney cancer-UROCCR 58-NCT03293563.World J Urol. 2023 Feb;41(2):287-294. doi: 10.1007/s00345-020-03558-5. Epub 2021 Feb 19. World J Urol. 2023. PMID: 33606044
-
Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses.J Urol. 2015 Dec;194(6):1548-53. doi: 10.1016/j.juro.2015.06.076. Epub 2015 Jun 19. J Urol. 2015. PMID: 26094808
-
Impact of Renal Hilar Control on Outcomes of Robotic Partial Nephrectomy: Systematic Review and Cumulative Meta-analysis.Eur Urol Focus. 2019 Jul;5(4):619-635. doi: 10.1016/j.euf.2018.01.012. Epub 2018 Jul 14. Eur Urol Focus. 2019. PMID: 29422419
-
Simultaneous totally robotic rectal resection and partial nephrectomy: case report and review of literature.World J Surg Oncol. 2020 May 4;18(1):86. doi: 10.1186/s12957-020-01864-1. World J Surg Oncol. 2020. PMID: 32366262 Free PMC article. Review.
Cited by
-
Bladder cancer in patients younger than 40 years: outcomes from the National Cancer Database.World J Urol. 2021 Jun;39(6):1911-1916. doi: 10.1007/s00345-020-03376-9. Epub 2020 Jul 31. World J Urol. 2021. PMID: 32737581
-
Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.Clin Genitourin Cancer. 2020 Dec;18(6):e643-e650. doi: 10.1016/j.clgc.2020.03.011. Epub 2020 Mar 20. Clin Genitourin Cancer. 2020. PMID: 32389458 Free PMC article.
-
Epidemiology of Renal Cell Carcinoma.World J Oncol. 2020 Jun;11(3):79-87. doi: 10.14740/wjon1279. Epub 2020 May 14. World J Oncol. 2020. PMID: 32494314 Free PMC article. Review.
-
The Correlation of Clinicopathological Features With the Status of Surgical Margins in Renal Cell Cancer Patients Following Nephron-Sparing Surgery: A Systematic Review and Meta-Analysis.Front Oncol. 2019 Jul 18;9:648. doi: 10.3389/fonc.2019.00648. eCollection 2019. Front Oncol. 2019. PMID: 31380284 Free PMC article.
-
The Clinicopathological Risk Factors in Renal Cell Cancer for the Oncological Outcomes Following Nephron-Sparing Surgery: A PRISMA Systematic Review and Meta-Analysis.Front Oncol. 2020 Mar 6;10:286. doi: 10.3389/fonc.2020.00286. eCollection 2020. Front Oncol. 2020. PMID: 32211325 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous